Human cytomegalovirus offers new hope in the treatment of deadly brain tumors

By  

Future Oncology, Vol. 3, Iss. 6, 2007-12 ,pp. : 601-603

Future Medicine

Access to resources Recommend Favorite

Urgent treatment of patients with metastatic melanoma using braf inhibitors in the absence of braf mutation status

By Nathan P.   Sharma A.   Lorigan P.  

Annals of Oncology, Vol. 24, Iss. 6, 2013-06 ,pp. : 1712-1713

Oxford University Press

Access to resources Recommend Favorite

From targeted monotherapy to combined BRAF–MEK inhibitors and integrated genome analysis for melanoma treatment

By Roukos Dimitrios H   Papaloukas Costas   Tzaphlidou Margaret  

Future Oncology, Vol. 9, Iss. 1, 2013-01 ,pp. : 5-8

Future Medicine

Access to resources Recommend Favorite

Implication of Unfolded Protein Response and Autophagy in the Treatment of BRAF Inhibitor Resistant Melanoma

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 3, 2016-02 ,pp. : 291-298

Bentham Science Publishers

Access to resources Recommend Favorite

Rationally Designed Drug Development Beyond BRAF Inhibition in Metastatic Cutaneous Melanoma

By Lemech C.R.   Arkenau H.-T.  

Cancer Hallmarks, Vol. 1, Iss. 1, 2013-04 ,pp. : 37-49

American Scientific Publishers

Access to resources Recommend Favorite